GENETISCHER TEST FÜR ZYTOCHROM-P450

Polymorphisms at positions 100, 271, 281, 294, 408, 506 or 1432 of the cytochrome P450 enzyme bufuralol-1'-hydroxylase are indicative of the extensive metaboliser/poor metaboliser phenotypes and can be detected using known methods such as amplification of the DNA with the polymerase chain react...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: WOLF, CHARLES ROLAND IMPERIAL CANCER RESEARCH FUND, GEORGE SQUARE EDINBURGH EH8 9XD, GB, MILES, JOHN, STEPHEN DEPARTMENT OF BIOISTRY, GLASGOW G12 8QQ, GB, GOUGH, ALAN, CHARLES IMPERIAL CANCER RESEARCH FUND, SOUTH MIMMS, POTTERS BAR HERTS EN6 3LD, GB, SPURR, NIGEL, KAY IMPERIAL CANCER RESEARCHFUND, SOUTH MIMMS, POTTERS BAR HERTS EN6 3LD, GB
Format: Patent
Sprache:ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Polymorphisms at positions 100, 271, 281, 294, 408, 506 or 1432 of the cytochrome P450 enzyme bufuralol-1'-hydroxylase are indicative of the extensive metaboliser/poor metaboliser phenotypes and can be detected using known methods such as amplification of the DNA with the polymerase chain reaction, followed by digestion with a suitable restriction enzyme and analysis by gel electrophoresis. The EM/PM phenotype is relevant to calculating safe or effective drug doses for individuals.